CytomX Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: CytomX Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: CytomX Therapeutics Inc
Rating: 0.785805625
Author: Trendlyne DVM scores

Momentum Trap

about

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics...

3.40 0.13 (3.98%)

58.59% Fall from 52W High

28.9M

XNAS Volume

High volume today

XNAS 26 Jun, 2026 5:30 PM (EDT)

Low Financial Strength

5.6 / 100

Expensive Valuation

14.8 / 100

Technically Neutral

36.9 / 100

Momentum Trap These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution View Similar Embed DVM

1Yr Price target upside is 268%

8 analysts

CytomX Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

CytomX Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics...

58.59% Fall from 52W High

High volume today

SWOT Analysis

CytomX Therapeutics Inc Live Price Chart